Induction of melanoma specific monocyte cytotoxicity in patients receiving BCG immunotherapy
Dufour, F.D.; Morton, D.L.
Surgical Forum 28: 165-167
1977
ISSN/ISBN: 0071-8041 PMID: 617405 Document Number: 116093
Document emailed within 1 workday
Related Documents
Martin, J.H.; Edwards, S.W. 1993: Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing Journal of Immunology 150(8 Pt 1): 3478-3486Lotem, M.; Shiloni, E.; Ingber, A.; Peretz, T. 1997: Active specific immunotherapy of malignant melanoma Harefuah 133(3-4): 122-126
Mutzner, P.A.; Stuhlmiller, G.M.; Seigler, H.F.; Stumpf, W.E.; Sar, M. 1981: Basis for a specific-active immunotherapy in malignant melanoma Schweizerische Medizinische Wochenschrift 111(36): 1322-1325
Bast, R.C.; Knapp, R.C.; Mitchell, A.K.; Thurston, J.G.; Tucker, R.W.; Schlossman, S.F. 1979: Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity Journal of Immunology 123(5): 1945-1951
Nissen-Meyer, J.; Austgulen, R.; Espevik, T. 1987: Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity Cancer Research 47(9): 2251-2258
Roll, A.; Hofbauer, G.; Ballmer-Weber, B.K.; Schmid-Grendelmeier, P. 2006: Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy Journal of Investigational Allergology and Clinical Immunology 16(2): 79-85
Siders, W.M.; Halloran, P.J.; Fenton, R.G. 1998: Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus Cancer Gene Therapy 5(5): 281-291
Rogala, B.; Glück, J. 1999: Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy Journal of Investigational Allergology and Clinical Immunology 9(3): 183-189
Rogala, B.; Jarzab, J.; Rymarczyk, B.; Tłuczykont, B. 2004: Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy Wiadomosci Lekarskie 57(3-4): 123-130
Morisaki, T.; Matsumoto, K.; Kuroki, H.; Kubo, M.; Baba, E.; Onishi, H.; Tasaki, A.; Nakamura, M.; Inaba, S.; Katano, M. 2003: Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion Anticancer Research 23(6a): 4459-4465
Rudolf, Z.; Sersa, G.; Krosl, G. 1986: In vitro monocyte maturation in patients with malignant melanoma and colorectal cancer--clinical significance Neoplasma 33(1): 71-78
Waldmann, T.A.; Goldman, C.K. 1989: The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 14(5 Suppl 2: 45-53
Kovarík, J.; Ninger, E.; Mechl, Z.; Zemanová, D.; Lauerová, L.; Sopková, B.; Svejda, J.; Bacovský, B.; Bártová, A.; Bártek, J. 1983: Immunotherapy and immune competence of patients with malignant melanoma Czechoslovak Medicine 6(3): 172-174
Fidler, J.M. 1978: The induction of hapten-specific immunologic tolerance and immunity in B lymphocytes. IV. Induction of TNP-specific unresponsiveness in vitro with serum from tolerant mice Journal of Immunology 121(4): 1558-1565
Locker, G.J.; Kofler, J.; Stoiser, B.; Wilfing, A.; Wenzel, C.; Wögerbauer, M.; Steger, G.G.; Zielinski, C.C.; Mader, R.; Burgmann, H. 2000: Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2 European Cytokine Network 11(3): 391-396
Peter, H.H.; Knoop, F.; Kalden, J.R. 1976: Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 151(3): 263-281
Pehamberger, H.; Ludwig, H.; Pötzi, P.; Pietschmann, H.; Knapp, W. 1979: Monocyte cytotoxicity in Hodgkin's disease Acta Medica Austriaca 6(5): 249-251
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405
Rogala, E.; Jarzab, J.; Brewczyński, P. 1984: Immune complexes during specific immunotherapy in patients with hay fever Polski Tygodnik Lekarski 39(31): 1027-1029
Lee, D.S.; White, D.E.; Hurst, R.; Rosenberg, S.A.; Yang, J.C. 1998: Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy Cancer Journal From Scientific American 4(2): 86-93